跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JORVEZA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
JORVEZA
Authorized
STANDARD
JORVEZA
avir pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2c5e39b79c835102
Company
avir pharma inc.
Type
Standard
Approval Details
Approval Id
2c5e39b79c835102
Drug Approval Canada Name
JORVEZA
Product Name
JORVEZA
Status
Marketed
Status Date
2021-10-19
Original Market Date
2021-10-19
Din
02513854
Drug Class
Human
Dosage Form
Tablet (Orally Disintegrating)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:04.00
Atc Original
A07EA06 BUDESONIDE
Atc Name
a 07 ea 06
Aig Number
0116807011
Company Name
avir pharma inc.
Company Address
660 Boulevard Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
BUDESONIDE
0.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2c5e39b79c835102
Type
Standard
Back to Health Canada Approvals